Reducing interference between oilcontaining adjuvants and surfactantcontaining antigens

Details for Australian Patent Application No. 2006274647 (hide)

Owner Novartis Vaccines and Diagnostics SRL

Inventors Contorni, Mario

Agent FB Rice

Pub. Number AU-A-2006274647

PCT Pub. Number WO2007/015167

Priority 0515906.6 02.08.05 GB; 0523923.1 24.11.05 GB; 0522599.0 04.11.05 GB

Filing date 2 August 2006

Wipo publication date 8 February 2007

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/015167 Priority application(s): WO2007/015167

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274651-Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine

2006274645-Compositions comprising (poly) alpha olefins